Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Dillon

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
British Journal of Pharmacology|May 1, 1988
The Ca2+ -antagonist and binding properties of the phenylalkylamine, anipamilJ S Dillon, W G Nayler
British Journal of Pharmacology|January 1, 1987
[3H]-verapamil binding to rat cardiac sarcolemmal membrane fragments; an effect of ischaemiaJ S Dillon, W G Nayler
European Journal of Clinical Pharmacology|January 1, 1990
Effect of verapamil withdrawal on cardiac beta 1-adrenoceptor densityW G Nayler, J S Dillon
British Journal of Clinical Pharmacology|January 1, 1986
Calcium antagonists and their mode of action: an historical overviewW G Nayler, J S Dillon
Clinical and Experimental Pharmacology & Physiology|February 1, 1988
Calcium antagonists and hypertensionW G Nayler, J S Dillon, W J Sturrock
Journal of Molecular and Cellular Cardiology|August 1, 1988
Alpha 1 adrenoceptors in the ischaemic and reperfused myocardiumJ S Dillon, X H Gu, W G Nayler
Biochemical Pharmacology|June 15, 1989
The effect of hypoxia and of energy depletion on 1,4-dihydropyridine binding sites in rat cardiac membrane fragmentsX H Gu, J S Dillon, W G Nayler
Journal of Cardiovascular Pharmacology|August 1, 1989
Effect of age and of hypertrophy on cardiac Ca2+ antagonist binding sitesJ S Dillon, X H Gu, W G Nayler
Journal of Cardiovascular Pharmacology|January 1, 1988
Chronic calcium antagonist therapy: some unexpected resultsW G Nayler, W J Sturrock, J S Dillon
Journal of Cardiovascular Pharmacology|September 1, 1988
Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and timeX H Gu, J S Dillon, W G Nayler
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
British Journal of Pharmacology|May 1, 1988
The Ca2+ -antagonist and binding properties of the phenylalkylamine, anipamilJ S Dillon, W G Nayler
British Journal of Pharmacology|January 1, 1987
[3H]-verapamil binding to rat cardiac sarcolemmal membrane fragments; an effect of ischaemiaJ S Dillon, W G Nayler
European Journal of Clinical Pharmacology|January 1, 1990
Effect of verapamil withdrawal on cardiac beta 1-adrenoceptor densityW G Nayler, J S Dillon
British Journal of Clinical Pharmacology|January 1, 1986
Calcium antagonists and their mode of action: an historical overviewW G Nayler, J S Dillon
Clinical and Experimental Pharmacology & Physiology|February 1, 1988
Calcium antagonists and hypertensionW G Nayler, J S Dillon, W J Sturrock
Journal of Molecular and Cellular Cardiology|August 1, 1988
Alpha 1 adrenoceptors in the ischaemic and reperfused myocardiumJ S Dillon, X H Gu, W G Nayler
Biochemical Pharmacology|June 15, 1989
The effect of hypoxia and of energy depletion on 1,4-dihydropyridine binding sites in rat cardiac membrane fragmentsX H Gu, J S Dillon, W G Nayler
Journal of Cardiovascular Pharmacology|August 1, 1989
Effect of age and of hypertrophy on cardiac Ca2+ antagonist binding sitesJ S Dillon, X H Gu, W G Nayler
Journal of Cardiovascular Pharmacology|January 1, 1988
Chronic calcium antagonist therapy: some unexpected resultsW G Nayler, W J Sturrock, J S Dillon
Journal of Cardiovascular Pharmacology|September 1, 1988
Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and timeX H Gu, J S Dillon, W G Nayler
Pageof 2